Last week Alabama Attorney General Steve Marshall announced another victory in the state's ongoing legal battle against the opioid crisis, securing an estimated $11.725 million from a national settlement with eight drug makers accused of fueling the epidemic.

The agreement, part of a sweeping multistate deal, includes major pharmaceutical companies that manufactured opioid pills linked to widespread addiction and overdose deaths nationwide. With full participation from local governments, public hospitals and other agencies, Alabama stands to receive its share of the payout over the next decade according to a news release.

"This settlement marks another pivotal achievement in Alabama's aggressive and uniquely successful legal strategy to hold opioid manufacturers, distributors, and others accountable. Our states have faced unimaginable loss due to the widespread abuse and misuse of opioids, and we have responded with decisive legal action," Marshall said in the release.

The eight companies and their total contributions to the nationwide settlement are:

• Mylan (now part of Viatris), $284,447,916 over nine years

• Hikma, $95,818,293 over one to four years

• Amneal, $71,751,010 over 10 years

• Apotex, $63,682,369 in a single year

• Indivior, $38,022,450 over four years

• Sun, $30,992,087 over one to four years

• Alvogen, $18,680,162 in a single year

• Zydus, $14,859,220 in a single year

Along with the cash payments, some companies will provide free pharmaceutical products or equivalent funds. The settlements also include strict new limits: seven companies must stop promoting or marketing opioids, halt production of pills containing more than 40 mg of oxycodone each, and implement systems to detect and report suspicious orders.

Indivior, which specializes in treatments for opioid use disorder, agreed to stop manufacturing or selling opioid products for the next decade but will continue to offer medications for addiction treatment.

This latest agreement adds to the more than $300 million Alabama has already secured through similar lawsuits against opioid manufacturers, distributors and retailers. Funds will be used to support addiction prevention, treatment and recovery efforts statewide.